Physician profile
Stefanie Porter
NPI 1932599271
$2,271.48
in general payments reported to CMS, 2019-2025
14 companies · $947 in 2025
The $947 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.90 · 2022: $28.43 · 2023: $575 · 2024: $705 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,227.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $887.34 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque |
| Boston Scientific Corporation | $563.78 | 2023-2025 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $280.81 | 2025 | |
| Medtronic, INC. | $170.56 | 2024 | Corevalve Evolut R |
| Philips North America LLC | $104.34 | 2025 | Ecc Solutions, Mcot |
| Novo Nordisk INC | $60.30 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $43.92 | 2023 | Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.31 | 2024-2025 | Jardiance |
| Axonics, INC. | $28.43 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.41 | 2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $21.68 | 2023 | Onpattro |
| Amgen INC. | $17.59 | 2023 | Repatha |
| Atricure, INC. | $15.90 | 2021 | |
| Merck Sharp & Dohme LLC | $13.11 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefanie Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.